WVE-007 is a novel, long-acting GalNAc-siRNA targeting INHBE mRNA – a genetically validated target that provides a new ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

The complete 2024 report, previous years’ reports, and full study details are available online at go.osu.edu/efieldsreports. Printed 2024 reports are available at many county Ohio State University ...

A clinical trial of tecovirimat (TPOXX®, SIGA ... Inc. The Company's business model is based on licensing technology from TheraCour Pharma Inc. for specific application verticals of specific viruses, ...

FDA places a clinical hold on Atara's EBVALLO and ATA3219 programs due to GMP compliance issues at a third-party facility. Atara to pause new participant enrollment; CAR-T programs may suspend in ...

("Revance" together with Dermata "Companies") today announced the Companies have entered into a clinical trial collaboration agreement to evaluate the topical application of Xyngari™ (formerly ...

EAM Jaishankar, Assam CM Sarma discuss development initiatives in Assam and its centrality for success of India's Act East, BIMSTEC policies ...

Patient enrollment has been completed ahead of schedule in a Phase 2 clinical trial evaluating Contineum Therapeutics‘ PIPE-307, an oral therapy aiming to restore myelin — a process known as ...

Parikh, MD, MPP, medical director of the Data and Technology Applications Shared Resource ... a machine learning framework to "translate" clinical trial results to real-world populations.